Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Microscience advances oral typhoid vaccine into U.S. clinical trials

Oct. 11, 2002

Aventis Pasteur patents multivalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine

Oct. 9, 2002

ICAAC abstract details mechanism of action, effects in murine model of GVHD for PNP inhibitor

Oct. 7, 2002

Helivax to enter phase II Helicobacter trials

Oct. 7, 2002

Shionogi describes the isolation of IL-12 production inhibitor from plant

Oct. 7, 2002

Genteric receives SBIR grant to evaluate DNA vaccines

Oct. 4, 2002

Avant announces phase II Peru-15 results

Oct. 3, 2002

Two Shionogi patents describe novel immunosuppressant agents

Oct. 2, 2002

Novel immunosuppressants in early development at Sumitomo

Oct. 1, 2002

Positive phase I results for AGI-1096 in prevention of transplant rejection

Oct. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....